jyoung
09-17-2009, 06:50 PM
YM BioSciences Inc. (USA) (AMEX:YMI) is one of the top percentage gainers in the early morning trade. The stock rose 20.63% to $1.87 with a huge volume of 1.91 million shares. However the stock has galloped 650.96% in the last six months. Today September 17, 2009, YM BioSciences Inc. announced that nimotuzumab has been approved for marketing in Mexico. YM BioSciences Inc. also announced that it has enrolled the first two patients in its randomized, double-blind trial evaluating nimotuzumab in patients with brain metastases from non-small-cell lung cancer (NSCLC)……………
check out LiquidTycoon dot com bcuz they have a summary report on the company...cool site!
check out LiquidTycoon dot com bcuz they have a summary report on the company...cool site!